Market Newsdesk

ROSELAND, N.J., Jan. 11, 2021 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced that it has entered into an agreement with Bitmedical AG (“Bitmedical”) to distribute the CompuFlo® Epidural Instrument and CathCheck™ System, as well as related disposables in Switzerland and Austria. Bitmedical is a premier distributor of medical devices and equipment within Switzerland and Austria, supporting many of the leading global manufacturers in these markets.

Hansruedi Muehlegg, CEO Bitmedical stated: “We are impressed with Milestone Scientific’s CompuFlo® Epidural System following extensive due diligence and positive feedback from end users prior to entering this agreement. Our analysis found CompuFlo’s objective, quantifiable and real-time pressure detection provides a measure of safety not currently available in epidural anesthesia. In addition to the inclusion of this extraordinary precision instrument to our product portfolio, we look forward to working closely with Milestone to introduce the CompuFlo and CathCheck System across Austria and Switzerland.”

Arjan Haverhals, President of Milestone Scientific, further noted, “We are pleased to enter into this distribution agreement with Bitmedical in such a short period of time since our first contact in November of 2020, which we believe illustrates their confidence in the market potential for our instruments. Bitmedical is an ideal distribution partner as its principals have extensive expertise and proven track records launching new medical devices in Austria and Switzerland. We believe that the deep reach of Bitmedical into Austrian and Swiss hospitals, as well as their specific expertise in Intensive Care, Cardiac Surgery and Anesthesiology will further expand our European and international market presence. Besides his current role as CEO of Bitmedical, Hansruedi has a direct anesthesia background as a Clinical Registered Nurse Anesthetist, and thus is very familiar with the challenges associated with epidural procedures. We believe that Switzerland and Austria are important markets for us based on the growing number of epidural procedures in both childbirth and pain management.”

Leonard Osser, Interim Chief Executive Officer of Milestone Scientific, commented, “We are pleased to welcome Bitmedical as our exclusive distribution partner in the region. We have a shared vision of applying advanced technological solutions to enhance the patient experience. We look forward to working closely with Bitmedical in order to educate medical professionals in the region on the benefits of our system, which provides objective, quantifiable and real-time confirmation when accessing the epidural space. Penetrating the sizeable Austrian and Swiss markets is an important step forward in our commercial launch of the CompuFlo Epidural System in Europe. We look forward to adding new distributors, hospitals and key opinion leaders across Europe and worldwide.”

The clinical and safety benefits of the CompuFlo Epidural and CathCheck Systems are backed by extensive published clinical data demonstrating significant reductions in epidural punctures, as well as complication rates, and contribute to a significant savings of time on the part of anesthesiologists. Moreover, the CompuFlo Epidural Instrument has the potential to significantly reduce costs associated with morbidity, providing a direct economic benefit to healthcare institutions. Similarly, the CathCheck technology has the potential to transform the monitoring of catheter placement following an epidural procedure by confirming the placement of a catheter within 2 minutes, versus 20-40 minutes using conventional methods. 

About Bitmedical AG

Bitmedical AG is a distribution company for leading international manufacturers in Switzerland and Austria for over ten years. They represent a number of companies in the field of ICU, Anesthesiology, Cardiac Surgery, Orthopedics, and Laboratories. The companies represented include Medtronic, Rivanna and Thermacor and Tahat. The company is active in Switzerland and Austria with own direct sales organization, technical support, warehousing, logistics and administration. The company works together with all University Hospitals in Austria and Swizerland and has offices in Kaiseraugst Switzerland and Vienna, Austria. For more information please visit our website: https://www.bitmedical.com/

About Milestone Scientific Inc.

Milestone Scientific Inc. (MLSS) is a biomedical technology research and development company that patents, designs and develops innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications. Milestone’s computer-controlled systems are designed to make injections precise, efficient, and virtually painless. Milestone’s proprietary DPS Dynamic Pressure Sensing technology® is our technology platform that advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for cosmetic botulinum toxin injections, epidural space identification in regional anesthesia procedures and intra-articular joint injections. For more information please visit our website: www.milestonescientific.com.

Safe Harbor Statement

This press release contains forward-looking statements regarding the timing and financial impact of Milestone’s ability to implement its business plan, expected revenues, timing of regulatory approvals and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions, future business decisions and regulatory developments, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone’s control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone’s periodic filings with the Securities and Exchange Commission, including without limitation, Milestone’s Annual Report for the year ended December 31, 2019. The forward-looking statements in this press release are based upon management’s reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

Contact:

David Waldman or Natalya Rudman
Crescendo Communications, LLC
Email: [email protected]
Tel: 212-671-1020

• EV Routing delivers the most optimal route including charging time
• Trips and charging stops can be planned to take into account both static and dynamic data

January 11, 2021

CES 2021 – Range anxiety is a key concern for many drivers. Therefore, ensuring easy and fast access to chargepoints is essential to persuading drivers to switch to EV vehicles. At the same time, many players in the ride-hailing industry have pledged to electrify their whole fleets and some countries have committed to banning sales of conventional petrol and diesel engine cars. With that in mind, HERE Technologies is unveiling a new EV Routing feature to optimize both private and commercial electric vehicle routing while minimizing the number of charging stops and reducing battery charging times, based on the vehicle’s consumption model.

EV Routing takes into account topography, road geometry, real time traffic information and traffic patterns while planning trips. It can be synced to the consumption model of the vehicle and can be adjusted to different driving styles, loads or weather conditions. EV Routing is a feature of a routing API built on top of HERE map and is included in Advanced Driver Assistance Systems (ADAS) products. It also leverages HERE EV Charge Points, a database that includes vehicle brand, real time availability of charging stations, subscription and pricing information.

“EV Routing does more than show you the way to a charging station. It provides the most optimal route, including charging times, while taking into account static and dynamic data such as charging speed or real time traffic conditions. Not only is EV Routing based on a wide range of parameters, it can also be customized. With EV Routing, HERE goes beyond removing range anxiety and makes EV driving a truly personalized experience,” said Jussi Koski, VP Product Management at HERE Technologies.

Media Contact

Adrianne Montgobert
+49 151 72 11 67 81
[email protected]

About HERE Technologies

HERE, a location data and technology platform, moves people, businesses and cities forward by harnessing the power of location. By leveraging our open platform, we empower our customers to achieve better outcomes – from helping a city manage its infrastructure or a business optimize its assets to guiding drivers to their destination safely. To learn more about HERE, please visit www.here.com and http://360.here.com.

 

Attachment

• Leia Inc., Continental and HERE Technologies to pave the way in bringing freshest 3D maps to vehicles

PR N° C2977C

STMicroelectronics Appointed Rajita D’Souza as
President, Human Resources and Corporate Social Responsibility

Geneva – January 11, 2021 – STMicroelectronics (NYSE: STM), a global semiconductor leader serving customers across the spectrum of electronics applications, announced today the appointment of Rajita D’Souza as President, Human Resources and Corporate Social Responsibility (CHRO). Effective Jan 1, 2021, she reports directly to Jean-Marc Chery, President and CEO and is a member of ST’s Executive Committee.

In her role, Rajita D’Souza is responsible for leading ST’s global HR organization (people development, performance management, compensation & benefits, recruitment), and will play a critical role in driving the company’s sustainability strategy and programs including ST’s goal to be carbon neutral by 2027.

Previously Chief Human Resources Officer at Bekaert, a world market and technology leader in steel wire transformation and coating technologies, Rajita D’Souza has wide experience in large industrial companies. She started her career in 1993 as Manager Operations with Reliance Consultancy Services in Mumbai, India. In 1997, she joined General Electric, where she held various HR leadership positions with increasing responsibility and scope. Ten years later, she moved to SABIC to become Director Human Resources in Europe. In 2011, she was appointed Vice President Human Resources for the EMEA region of The Goodyear Tire & Rubber Company.

Rajita D’Souza was born in Mumbai, India, in 1973. She holds a master’s degree in Law from the University of Mumbai and a bachelor’s degree in Business Management. She is also a certified Master Black-Belt in Six Sigma quality.

About STMicroelectronics

At ST, we are 46,000 creators and makers of semiconductor technologies mastering the semiconductor supply chain with state-of-the-art manufacturing facilities. An independent device manufacturer, we work with our 100,000 customers and thousands of partners to design and build products, solutions, and ecosystems that address their challenges and opportunities, and the need to support a more sustainable world. Our technologies enable smarter mobility, more efficient power and energy management, and the wide-scale deployment of the Internet of Things and 5G technology. Further information can be found at www.st.com.

MEDIA RELATIONS:
Alexis Breton
Corporate External Communications
Tel: + 33 6 59 16 79 08
[email protected]

Attachment

• C2977C — Jan 11 2021 –Rajita appointment_FINAL FOR PUBLICATION

January 11, 2021

• Beyond COVID-19, Philips spotlights care outside of hospital settings in unique, interactive virtual experience
• Philips executives
  Deeptha Khanna and Jeroen Tas talk digital health tech in virtual press conference during CES 2021 Media Day
• Philips named CES 2021 Innovation Awards honoree for outstanding technology products across personal and professional health

Amsterdam, the Netherlands –

Royal Philips
(NYSE: PHG, AEX: PHIA), a global leader in health technology, announced its participation in the first-ever, all-digital CES 2021, beginning today and running through Jan. 14. Since the initial outbreak of COVID-19 a year ago, healthcare has experienced a rapid transformation and acceleration of digital health technologies. During CES 2021, Philips will highlight a unique hybrid view of advanced technology solutions fast-tracking healthcare, moving outside the four walls of the hospital and into the home. 

Telehealth, including tele-dentistry, virtual care and remote monitoring have played significant roles during the pandemic and will continue to play central roles in health and well-being post COVID-19 and beyond. At this year’s CES 2021, Philips has created an interactive virtual healthy neighborhood that visitors can self-navigate. The immersive experience brings three core storylines to life, demonstrating how Philips digital health technology is supporting consumers and patients alike during COVID-19. From first-time expecting parents, to at-risk people living with chronic – and often related – conditions like cardiac disease, diabetes, or sleep apnea, to those who want to improve their oral health, Philips will spotlight end-to-end solutions to help safely evaluate and monitor people to better manage healthcare at home.

Philips CES 2021 virtual press conference

Philips executives Deeptha Khanna, Chief Business Leader of Personal Health, and Jeroen Tas, Chief Innovation & Strategy Officer, will participate in the Philips CES 2021 virtual press conference on Monday, January 11 at 10:00 a.m. EST to discuss their vision and experience in the consumer and professional health tech space.

“Since the onset of the pandemic, we have witnessed a dramatic shift to online, with the majority of our activities now centered in the home. We’re working, shopping, educating and connecting with our caregivers, all from the comfort of our homes. In fact, nearly half of our Personal Health sales are now made online,” said Deeptha Khanna, Chief Business Leader, Personal Health, Philips. “We have also witnessed the reinvention of our homes as a core element of the healthcare pathway, with telehealth, virtual and remote care technologies as the key drivers for change during COVID-19. And these changes are here to stay.”

Philips spotlights remote monitoring, virtual care and digital health solutions at CES 2021

Pregnant mothers are a vulnerable population and may have several concerns and anxieties about the impact of COVID-19 infection on pregnancy [1]. Philips COVID-19 Fetal and Maternal solution within the Avalon product family, including patch and digital twin of the fetal monitor, allows clinicians to monitor vital signs of both mom and baby from home or an isolation room to help reduce unnecessary physical interactions between clinicians and patients.

In the belief that parents should be able to make decisions based on the best possible evidence, Philips and GSK have teamed up to equip Philips’ Pregnancy+ and Baby+ apps with comprehensive and reliable information about vaccine preventable diseases and the vaccines that are available. The apps, reaching a combined total of nearly 2 million parents worldwide every day, provide articles and videos about the importance of vaccination, together with a vaccination hub to help parents access comprehensive and reliable information to support conversations with their healthcare professionals, such as which vaccines are relevant and when they need to be administered. Parents are also invited to participate in on-line research to help to better understand their views on different vaccinations.

For people living with health conditions like diabetes or cardiac disease, Philips will highlight its recently introduced biosensor-based solutions for remote monitoring of at-risk chronic disease patients as they transition from the hospital into the home. Philips will also spotlight  its end-to-end, clinically proven sleep solutions, designed to help address chronic sleep conditions like sleep apnea from discovery, to diagnosis, through treatment and adherence – even from the home. Being showcased for the first time at CES is the Philips Mask Selector, the first and only clinically validated, 3D facial scanning solution that helps providers fit 9 out of 10 patients with the right mask from the start [2]. The proprietary Mask Selector algorithm offers a novel solution in the shift toward digitization of health care, helping to improve business efficiencies by reducing costs associated with fitting time and mask waste.

Philips debuts new Philips Sonicare 9900 Prestige at CES

As dentist offices closed for a significant period of time during the height of the pandemic, routine face-to-face dental check-ups came to a standstill. Taking care of oral health at home became more important than ever before. Earlier today, Philips announced the commercial launch of its most recent addition to the Sonicare line of advanced oral care products with the introduction of the Sonicare 9900 Prestige. This latest power toothbrush with Philips SenseIQ technology and in-built artificial intelligence helps make daily brushing as effective as possible. The Sonicare 9900 Prestige is designed to sense, adapt and care for a personalized approach to oral care. It is intuitive, adjusting its settings to a consumer’s personal brushing behavior.  For instance, when applying too much pressure, it automatically adjusts the brushing intensity.

Philips addresses key areas of health tech focus in CES panel speaker sessions
During CES 2021, Pat Baird, Regulatory Standards Specialist and Global Head of Software Standards at Philips will address the trustworthiness of AI in healthcare through the lens of the end user including physicians, consumers, professional and family caregivers, public health leaders, medical societies, and regulators. Joining Philips in the discussion on Trust and the impact of AI on healthcare are Dr. Jesse Ehrenfeld, MD, American Medical Association, and Christina Silcox, PhD, Managing Associate at the Duke-Margolis Center for Health Policy at Duke University. CES attendees can join the panel session, Jan. 12 at 10:15 a.m. EST.

Building sustainability and battling climate change
Robert Metzke, Global Head of Sustainability for Philips will also speak at CES during an in-depth fireside chat titled “Building Sustainability and Battling Climate Change.” Robert will give his views on how business leaders are increasingly acknowledging how critical sustainability is to the future. This session will premiere on Jan. 13 at 11:30 a.m. EST. Both speaker sessions will be available on demand for 30 days to all registered CES attendees following the event.

Philips named CES 2021 Innovation Awards honoree

On Dec. 15, the Consumer Technology Association (CTA)® announced the CES® 2021 Innovation Awards honorees, including those products recognized as Best of Innovation. Honorees are recognized for outstanding products, upcoming trends and how companies are using technology to change lives for the better. Philips been named a CES® 2021 Innovation Awards honoree recognized for multiple technology solutions across personal and professional health including the Philips Patient Monitoring Kit; the Philips Wearable Biosensor; the Philips Mask Selector; the Philips Sonicare Prestige 9900; and Philips Teledentistry.

Visit the Philips exhibitor showcase at the all-digital CES 2021 to learn more and follow @PhilipsLiveFrom for live updates throughout the event. While the Philips virtual healthy neighborhood experience is built for CES, the platform will be live throughout the year to continue to demonstrate both Personal Health and Connected Care technology solutions supporting consumer health.

[1] Covid-19 related anxiety and concerns expressed by pregnant and post-partum women – a survey among obstetricians (nih.gov): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445074/.
[2] 2019 Philips sponsored patient preference trial (n=310). Patients scanned using Mask Selector (n=153) vs. traditional fitting methods (n=157).

For further information, please contact:

Kathy O’Reilly
Philips Global Press Office
Tel.: +1 978-221-8919
E-mail : [email protected]
Twitter: @kathyoreilly

Laura Seikritt
Philips Global Press Office
Tel: +31 6 20740318
E-mail: [email protected]

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments

• Expecting parents
• Philips Mask Selector 3D CPAP
• Philips Avalon cableless fetal and maternal pod with single-use disposable patch
• Philips remote patient monitoring with BioIntelliSense BioSticker
• Philips Sonicare 9900 Prestige power toothbrush with Philips SenseIQ technology

KANSAS CITY, Mo., Jan. 11, 2021 (GLOBE NEWSWIRE) — Cerner Corporation (Nasdaq: CERN) today announced it will release its fourth quarter 2020 earnings results after the market closes Wednesday, February 10^th. Following the release, the company will hold a conference call at 3:30 p.m. CT that can be accessed via dial-in or webcast. On the call, Cerner will discuss its results and outlook and answer questions from the investment community. The call may also include discussion of Cerner developments and other material and forward-looking information about business and financial matters.

The dial-in number for the conference call is (678) 509-7542; the passcode is Cerner. The company recommends joining the call 15 minutes early for registration. An audio webcast will be available live and archived on Cerner’s website in the Investor Relations section.

About Cerner

Cerner’s health technologies connect people and information systems at thousands of contracted provider facilities worldwide dedicated to creating smarter and better care for individuals and communities. Recognized globally for innovation, Cerner assists clinicians in making care decisions and assists organizations in managing the health of their populations. The company also offers an integrated clinical and financial system to help manage day-to-day revenue functions, as well as a wide range of services to support clinical, financial and operational needs, focused on people. For more information, visit Cerner.com, The Cerner Blog, The Cerner Podcast or connect on Facebook, Instagram, LinkedIn or Twitter. Nasdaq: CERN. Health care is too important to stay the same.

Media Contact: Stephanie Greenwood, Public Relations, (816) 201-2137
Investor Contact: Allan Kells, Investor Relations, (816) 201-2445

NEWTON, Mass., Jan. 11, 2021 (GLOBE NEWSWIRE) — An early analysis of 2020 restaurant gift card sales by Paytronix Systems, Inc., the most advanced digital guest experience platform, found that while holiday card sales accounted for the same percentage of annual sales as previous years, overall card sales ended the year down 31.8% when compared with 2019. Per-card spending remained relatively consistent when compared with previous years.

Paytronix data shows that holiday sales – those that occurred during November and December – accounted for 45.8% of all restaurant gift card sales in 2020, and approximately 48.6% of all gift card spend. This is on par with the previous three years, during which holiday card sales accounted for an average of 46.3% of all annual gift card sales.  

Despite a nearly one-third decline in overall card sales, the average dollar amount loaded onto each card remained fairly consistent in 2020, indicating that guests maintained their spending power. Fine Dining restaurants fared exceptionally well in this regard, realizing a 7.7% increase in the average spend per gift card over the course of the year.  

Full Service Restaurants (FSRs), meanwhile, took the brunt of the losses in 2020. FSRs’ share of the market fell by more than 15% to account for just 26.3% of gift card sales across restaurant sectors. The bulk of those sales were recouped by Quick Service Restaurants (QSRs), which accounted for 66.5% of sales in 2020. The remaining two restaurant types – Fast Casual and Fine Dining – accounted for 4.5% and 2.7% of annual gift card sales, respectively.  

“Guests appear to have opted for either QSRs or Fine Dining over FSRs in 2020. QSRs have emerged as the big winner throughout the pandemic, so it’s no surprise to see them with strong gift card numbers. The Fine Dining category is interesting, because it suggests that people still crave a dining experience, either through high-quality food or in the hope that they can dine-in soon,” said Lee Barnes, head of Paytronix Data Insights. 

Even as sales were lower this year, traditional sales patterns continued to hold. The holiday season kicked off with Black Friday sales down 30.1% from previous years, then experienced a last-minute peak in the last few days leading up to Christmas.

The holiday sales analysis is a key component in the development of the Paytronix Annual Gift Card Sales Report, which will be available later this year. That Report offers an in-depth look into holiday gift card sales, sales by channel and service type, anticipated redemption and new insights on eGift cards. With the online ordering industry expanding, the Report also examines the impact of gift cards redeemed online.

Sign up in advance on the Paytronix website to receive the full report when it becomes available.

Methodology

Following trends in closed-loop restaurant gift card sales, the Paytronix gift card sales research includes data from gift card sales on between November 1, 2020 and December 31, 2020 and includes 192 brands.

Paytronix
Systems, Inc.

Based in Newton, Massachusetts, Paytronix is a provider of SaaS customer experience management (CXM) solutions for restaurants and convenience stores. Through its innovative software design and integrations with more than 30 widely used point-of-sale systems, Paytronix empowers more than 500 brands across 30,000 locations, giving them the flexibility to deliver unique, revenue-enhancing guest experiences. Through one-to-one engagement with more than 285 million guests via Order & Delivery, Loyalty, CRM, and Stored Value, Paytronix generates Big Data consumer insights that motivate increased visits and spend. For more information, visit www.paytronix.com.

Media Contact:


Chuck Tanowitz
Paytronix Systems, Inc.
617-871-2319

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/53174354-2b7a-4cf2-99db-a978eec4cf17

[email protected]

WESTLAKE VILLAGE, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced that Matthew Moore has joined the company as Chief Business Officer. Mr. Moore brings to Arcutis over 20 years of strategy, transaction and operations experience in the biopharmaceutical industry. Most recently, he served as Vice President, Corporate Business Development and Alliance Management at Allergan, where he led worldwide strategy and business development for the company’s $4B+ Medical Aesthetics business unit.

“We are thrilled to add Matt to our executive team. Like the rest of our senior team, Matt brings a deep understanding of dermatology markets, and he adds important expertise in corporate strategy, business development, and alliance management. His extensive experience creating shareholder value through successful business development will be a key enabler as we continue to build Arcutis into one of the industry’s leading dermatology companies,” said Frank Watanabe, Arcutis’ President and Chief Executive Officer. “We at Arcutis are focused on elevating the standard of care for dermatological diseases, and his strategic insights and deal execution will play an important role in helping us to realize that goal.”

“I am delighted to join Arcutis at such an exciting time for the company,” said Mr. Moore. “Arcutis has established itself as a leader in medical dermatology and is uniquely positioned to fill the innovation gap in this therapeutic area. I have been impressed by the pace of progress achieved to date, and look forward to working with the team to help make Arcutis the preeminent, innovation-driven medical dermatology company.”

During his tenure at Allergan and its predecessor companies, Actavis and Forest Labs, Mr. Moore was responsible for creating and executing business development growth strategies across multiple therapeutic areas including medical aesthetics, neuroscience, anti-infectives and hospital products. In addition, Mr. Moore served as a key deal team member in Actavis’ transformational acquisition of Allergan and Allergan’s ultimate sale to AbbVie. Prior to Allergan, Mr. Moore held executive roles at DOV Pharmaceutical and he started his career in the healthcare investment banking group at CIBC Oppenheimer. Mr. Moore earned his B.A. in Psychology from Trinity College.

About Arcutis – Bioscience, applied to the skin.
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology. The company is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. Arcutis’ robust pipeline includes four novel drug candidates currently in development for a range of inflammatory dermatological conditions. The company’s lead product candidate, topical roflumilast, has the potential to revitalize the standard of care for plaque psoriasis, atopic dermatitis, scalp psoriasis, and seborrheic dermatitis. For more information, visit https://www.arcutis.com or follow the company on LinkedIn and Twitter.

Forward Looking Statements

This press release contains “forward-looking” statements, including, among others, statements regarding the potential for Arcutis to become the preeminent, innovation-driven medical dermatology company. These statements involve substantial known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements and you should not place undue reliance on our forward-looking statements. Risks and uncertainties that may cause our actual results to differ include risks inherent in the clinical development process and regulatory approval process, the timing of regulatory filings, and our ability to defend our intellectual property. For a further description of the risks and uncertainties applicable to our business, see the “Risk Factors” section of our Form 10-Q filed with U.S. Securities and Exchange Commission (SEC) on November 5, 2020, as well as any subsequent filings with the SEC. We undertake no obligation to revise or update information herein to reflect events or circumstances in the future, even if new information becomes available.

Investors and Media:

Heather Rowe Armstrong
Vice President, Investor Relations & Corporate Communications
[email protected]
805-418-5006, Ext. 740

Miami Gardens, Fla, Jan. 11, 2021 (GLOBE NEWSWIRE) — Centerplate, the leading hospitality partner to North America’s premier sports entertainment venues, today announced an array of specialty menu items for Monday’s highly anticipated College Football Playoff National Championship between the Alabama Crimson Tide and Ohio State Buckeyes. This is the first time the game will be played in Miami, and the food and beverage experience will rise to the occasion, while ensuring all of the appropriate safety protocols for the expected 13,000 fans in attendance. Everything has been coordinated within local, NFL, and CDC guidelines to help limit the spread of COVID-19.

Hard Rock Stadium, a global entertainment destination, was the first stadium worldwide to receive GBAC STAR accreditation. The stadium successfully completed 20 program elements with specific performance and guidance criteria to earn accreditation and has been safely hosting professional and collegiate football games over the past few months, as well as an outdoor theater experience. This video details the safety protocols that have been installed.

“Although this year will look different, this is a championship matchup, and we are prepared to provide a championship level of hospitality,” said Centerplate Chief Executive Office Steve Pangburn. “We are sourcing from South Florida purveyors and employing nearly 1,000 employees to help boost the regional economy and will help curate the finest fan experience in the safest environment possible.”  

The experience will feature an online order-ahead food and beverage option via the stadium app, with distinct pickup-only locations in the stadium. There will also be a limited concessions menu featuring only the most popular items and more pre-packaged offerings, to reduce wait time and crowding on the concourses, so people can return to their seats faster.

“The health and safety of everyone continues to be our top priority for the national championship game,” said Miami Dolphins and Hard Rock Stadium Vice Chairman and CEO Tom Garfinkel. “We hope the diligent planning that has gone into making Hard Rock Stadium a safe environment will create an enjoyable experience for all of our guests.”

Among other changes to the food and beverage program:

• Elimination of cash to reduce contact
• Elimination of condiment stands on the concourse
• Elimination of vendors walking up and down aisles
• Gloves and masks required for all food-service employees
• Social distance markings to encourage and promote distancing guidelines in common areas
• Buffet items to be served by both culinarians and private suite attendants

Bill Hancock, Executive Director of the College Football Playoff, added, “We know that everything will adhere to rigorous safety standards, while still providing students and fans a fun and tasty addition to their time at the College Football Playoff National Championship.”

There will also be team-inspired, locally authentic creations from Executive Chef Dayanny De la Cruz that will delight Alabama and Ohio State fans.

Finally, 20,000 of Ball Corporation’s infinitely recyclable aluminum cups will also be available for fans. Centerplate is adopting the cups as part of parent company Sodexo’s Better Tomorrow 2025 goals and to help forward Hard Rock Stadium’s broader mission to phase out 99.4 percent of single-use plastics at the venue. Hard Rock Stadium became the first professional football arena to feature the aluminum cups at scale when it debuted them during the Miami Dolphins’ final home game of the season in December 2019.

About Centerplate

Centerplate is a leader in live event hospitality, “Making It Better To Be There®” for more than 115 million guests each year at more than 200 prominent entertainment, sports and convention venues. From hosting VIPs at the Super Bowl to super heroes at Comic Con, the company provides hospitality services to North America’s premier events. A Sodexo company, Centerplate creates unique, locally-inspired menus, best-in-class guest service, and one-of-a-kind experiences backed by world-class design and insights teams. Visit the company online, connect via Twitter @centerplate, Instagram @Centerplate_ or Facebook.com/centerplate.

Attachments

• Chicken Pops on CP Board FOR WEB
• Hard Rock Stadium Cubano Sausage

Paul Pettas
Centerplate
[email protected]